New CRISPR Gene-Editing Treatment Approved In Europe : vimarsana.com

The decision comes after Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy was approved in the UK and US for sickle cell disease and beta thalassemia.

Related Keywords

Rome , Lazio , Italy , United Kingdom , Franco Locatelli , Drug Administration , European Commission , European Medicines Agency , European Union On , European Union , Catholic University Of The Sacred Heart , Catholic University , Sacred Heart , Casgevy , Vertex , Crispr , Gene Editing , Blood , Sickle Cell , Beta Thalassemia , Fda , Hemoglobin , Gene Therapy ,